"I want the best," Susan Ault remembers saying when her non-Hodgkin's lymphoma was discovered.  "I made 26 phone calls. And the Seattle Cancer Care Alliance was No. 1." Read Susan's Story >

Adult Bone Marrow Transplantation

Dr. E. Donnall Thomas and the Fred Hutchinson Cancer Research Center team of scientists are the pioneers of bone marrow transplantation (BMT), discovered over 40 years ago to treat leukemia, a once fatal disease.

Today, the success of bone marrow transplantation stands among the world's most significant medical advances. The technique has transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 90 percent.

Dr. Thomas received a Nobel Prize in 1990 for this groundbreaking work. (For the full story of Dr. Thomas' research and recognition, click here.)

Today, bone marrow transplantation is used to treat cancers and other diseases, including aplastic anemia, sickle cell anemia, immune deficiency disorders, and autoimmune diseases such as scleroderma and multiple sclerosis. Malignant diseases (cancers) treated with transplantation include acute and chronic leukemias, Hodgkin's disease and non-Hodgkin's lymphoma, myelodysplasia, multiple myeloma, myelofibrosis, and renal cell carcinoma.

As a result of our doctors’ expertise as pioneers in the field:

• Seattle Cancer Care Alliance transplant results are outstanding.
• We treat high-risk patients.
• We offer the latest therapies. 
• We have a unique long-term follow-up program.

At SCCA, you will receive the best possible medical care in an environment designed to support you and your family.

In the News

When Tyler Colosimo learned that doctors could find no suitable bone marrow donor worldwide to help save him from leukemia, he thought his days might be numbered. Now, Dr. Colleen Delaney, a Hutchinson Center oncologist and researcher, thinks she may have found a way around the problem. Read the article in the Seattle Times.

April 2008